There are 2137 resources available
1450P - Efficacy and safety analysis of modified biweekly SOX regimen in the first-line treatment of advanced gastric adenocarcinoma or esophagogastric junction adenocarcinoma
Presenter: Shu Zhang
Session: E-Poster Display
Resources:
Abstract
1451P - Comparative response evaluation of cisplatin-capecitabine with cisplatin-5-fluorouracil in advanced gastric carcinoma: A quasi-experimental study
Presenter: Ariful Hoque
Session: E-Poster Display
Resources:
Abstract
1452P - Phase I study of apatinib plus POF (paclitaxel plus FOLFOX) in patients (pts) with treatment-naïve advanced gastric cancer (TNAGC)
Presenter: Rongbo Lin
Session: E-Poster Display
Resources:
Abstract
1453P - Safety and efficacy of vactosertib, a TGF-βR1 kinase inhibitor, in combination with paclitaxel in patients with metastatic gastric adenocarcinoma
Presenter: Minkyu Jung
Session: E-Poster Display
Resources:
Abstract
1454P - PARAFIRIGAST: Paclitaxel/ramucirumab versus FOLFIRI as second line chemotherapy of metastatic gastric cancer: An AGEO multicenter comparative study with a propensity score analysis
Presenter: Julie Wasselin
Session: E-Poster Display
Resources:
Abstract
1455P - A single-arm, open-label, prospective, multicenter study of apatinib combined with chemotherapy as second-line therapy in patients with advanced gastric cancer
Presenter: Jifeng Feng
Session: E-Poster Display
Resources:
Abstract
1456P - Retrospective comparative analysis of S-1 and oxaliplatin or cisplatin as first-line therapy in metastatic gastric cancer in a European population
Presenter: Anna Koumarianou
Session: E-Poster Display
Resources:
Abstract
1457P - Real-world survival in advanced gastro-oesophageal adenocarcinoma with best supportive care
Presenter: Kirsty Cavanagh
Session: E-Poster Display
Resources:
Abstract
1458P - Real-world treatment patterns of unresectable advanced or synchronous metastatic esophageal squamous cell cancer in a Western population
Presenter: Marieke Pape
Session: E-Poster Display
Resources:
Abstract
1459P - Albumin as a simple criterion to reduce early mortality (EM) in gastric cancer (GC) trials
Presenter: Mustafa Ozguroglu
Session: E-Poster Display
Resources:
Abstract